Annual CFI:
-$62.85M-$62.82M(-261766.67%)Summary
- As of today, NAMS annual cash from investing is -$62.85 million, with the most recent change of -$62.82 million (-261766.67%) on December 31, 2024.
- During the last 3 years, NAMS annual cash from investing has fallen by -$62.82 million (-261766.67%).
- NAMS annual cash from investing is now -392700.00% below its all-time high of -$16.00 thousand, reached on December 1, 2020.
Performance
NAMS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
$2.51M+$161.64M(+101.57%)Summary
- As of today, NAMS quarterly cash from investing is $2.51 million, with the most recent change of +$161.64 million (+101.57%) on September 30, 2025.
- Over the past year, NAMS quarterly cash from investing has increased by +$2.58 million (+3441.33%).
- NAMS quarterly cash from investing is now -12.22% below its all-time high of $2.85 million, reached on March 31, 2025.
Performance
NAMS Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$215.95M+$2.58M(+1.18%)Summary
- As of today, NAMS TTM cash from investing is -$215.95 million, with the most recent change of +$2.58 million (+1.18%) on September 30, 2025.
- Over the past year, NAMS TTM cash from investing has dropped by -$215.28 million (-32180.12%).
Performance
NAMS TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
NAMS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -10000.0% | +3441.3% | -10000.0% |
| 3Y3 Years | -10000.0% | +100.0% | -100.0% |
| 5Y5 Years | -10000.0% | - | - |
NAMS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | >-9999.0% | at low | -12.2% | +101.6% | >-9999.0% | +1.2% |
| 5Y | 5-Year | >-9999.0% | at low | -12.2% | +101.6% | >-9999.0% | +1.2% |
| All-Time | All-Time | >-9999.0% | at low | -12.2% | +101.6% | >-9999.0% | +1.2% |
NAMS Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $2.51M(+101.6%) | -$215.95M(+1.2%) |
| Jun 2025 | - | -$159.14M(-5673.9%) | -$218.53M(-266.6%) |
| Mar 2025 | - | $2.85M(+104.6%) | -$59.61M(+5.2%) |
| Dec 2024 | -$62.85M(>-9900.0%) | -$62.18M(>-9900.0%) | -$62.85M(-9294.3%) |
| Sep 2024 | - | -$75.00K(+64.1%) | -$669.00K(-12.6%) |
| Jun 2024 | - | -$209.00K(+45.7%) | -$594.00K(-54.3%) |
| Mar 2024 | - | -$385.00K(-5400.0%) | -$385.00K(-5400.0%) |
| Dec 2023 | -$24.00K(+89.1%) | - | - |
| Mar 2023 | - | -$7000.00 | -$7000.00 |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$221.00K(-820.8%) | - | - |
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2021 | -$24.00K(-50.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00 | $0.00 |
| Dec 2020 | -$16.00K | - | - |
FAQ
- What is NewAmsterdam Pharma Company N.V. annual cash from investing?
- What is the all-time high annual cash from investing for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. annual cash from investing year-on-year change?
- What is NewAmsterdam Pharma Company N.V. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. quarterly cash from investing year-on-year change?
- What is NewAmsterdam Pharma Company N.V. TTM cash from investing?
- What is the all-time high TTM cash from investing for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. TTM cash from investing year-on-year change?
What is NewAmsterdam Pharma Company N.V. annual cash from investing?
The current annual cash from investing of NAMS is -$62.85M
What is the all-time high annual cash from investing for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high annual cash from investing is -$16.00K
What is NewAmsterdam Pharma Company N.V. annual cash from investing year-on-year change?
Over the past year, NAMS annual cash from investing has changed by -$62.82M (-261766.67%)
What is NewAmsterdam Pharma Company N.V. quarterly cash from investing?
The current quarterly cash from investing of NAMS is $2.51M
What is the all-time high quarterly cash from investing for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high quarterly cash from investing is $2.85M
What is NewAmsterdam Pharma Company N.V. quarterly cash from investing year-on-year change?
Over the past year, NAMS quarterly cash from investing has changed by +$2.58M (+3441.33%)
What is NewAmsterdam Pharma Company N.V. TTM cash from investing?
The current TTM cash from investing of NAMS is -$215.95M
What is the all-time high TTM cash from investing for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high TTM cash from investing is $0.00
What is NewAmsterdam Pharma Company N.V. TTM cash from investing year-on-year change?
Over the past year, NAMS TTM cash from investing has changed by -$215.28M (-32180.12%)